Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 21 - Drugs for disorders of the muscular or neuromuscular system
Patents for A61P 21 - Drugs for disorders of the muscular or neuromuscular system (23,287)
03/2012
03/06/2012US8129332 Reagents and methods for smooth muscle therapies
03/06/2012CA2487734C Treatment with cytokines for alzheimer's disease
03/06/2012CA2486055C Amines that inhibit a mammalian anandamide transporter, and methods of use thereof
03/01/2012WO2012027570A2 Dual variable domain immunoglobulins and uses thereof
03/01/2012WO2012026575A1 Muscle-enhancing agent
03/01/2012US20120053240 Method of Administering beta-hydroxy-beta-methylbutyrate (HMB)
03/01/2012US20120053210 Compounds that modulate intracellular calcium
03/01/2012US20120053186 2-(3-aminoaryl) amino-4-aryl-thiazoles and their use as c-kit inhibitors
03/01/2012US20120052129 Motor Function Improver
03/01/2012US20120052121 New combination of active ingredients containing a non steroidal anti inflammatory drug and a colchicoside derivative
03/01/2012US20120052005 Combination therapy to improve drug efficiency
02/2012
02/29/2012EP2421530A1 A novel formulation of metaxalone
02/29/2012EP2421512A1 A novel formulation of naproxen
02/29/2012CN102365269A Novel therapeutic agent for cognitive impairment
02/29/2012CN102363010A Chinese medicinal preparation for treating dermatomyositis
02/29/2012CN102362992A Chinese medicinal composition for treating dermatomyositis
02/29/2012CN102362972A Chinese medicine for treating dermatomyositis
02/29/2012CN102362961A Traditional Chinese medicinal formula for treating dermatomyositis
02/29/2012CN101711857B Film coating agent for treating whitevein and preparation method thereof
02/29/2012CN101700385B Pharmaceutical composition medicinal liquor or tincture for curing white vein disease and preparation method thereof
02/29/2012CN101698096B Plaster for treating white vein diseases and preparation method thereof
02/29/2012CN101484157B Agent for improving muscle power
02/28/2012CA2333951C Method for treating neurodegenerative disorders
02/23/2012WO2012024242A1 Antibodies that bind myostatin, compositions and methods
02/23/2012WO2011143526A9 Topical peripheral neuro-affective (tpna) therapy
02/23/2012US20120046441 Combinatorial Synthesis of Libraries of Macrocyclic Compounds Useful in Drug Discovery
02/23/2012US20120046342 Oligonucleotide comprising an inosine for treating dmd
02/23/2012US20120046274 6-alkenyl and 6-phenylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(adp-ribose) polymerase inhibitors
02/23/2012US20120046255 Non-steroidal compounds
02/23/2012US20120046252 Calcium Formate for Use as a Dietary Supplement
02/23/2012US20120045503 Compositions And Methods For Wound Healing
02/23/2012US20120045459 Methods for Treating Autophagy-Related Disorders
02/23/2012US20120045435 Compositions and methods to inhibit stem cell and progenitor cell binding to lymphoid tissue and for regenerating germinal centers in lymphatic tissues
02/23/2012US20120045430 Dendrimer-like modular delivery vector
02/23/2012CA2808382A1 Antibodies that bind myostatin, compositions and methods
02/22/2012EP2419101A2 Method of treating disorders associated with protein kinase ck2 activity
02/22/2012EP1853280B1 Compositions and methods for treating and preventing cardiomyopathy and heart disease
02/22/2012CN102357247A Therapeutic methods and delivery systems utilizing sex steroid precursors
02/22/2012CN102357098A Pharmaceutical composition, uses and preparing method thereof
02/22/2012CN102357062A Compositions and methods for topical application and transdermal delivery of botulinum toxins
02/21/2012US8119665 Aryl imidazoles and related compounds as C5a receptor modulators
02/21/2012US8119604 Polypeptide formulation
02/21/2012US8119370 Activatable recombinant neurotoxins
02/21/2012US8119141 Cinnamomi and poria composition, method to prepare same and uses thereof
02/21/2012US8119121 Delivering a concentrated amount of stem cells obtained from adipose tissue to a patient
02/21/2012CA2488372C Pyridazine derivatives which are phosphodiasterase iv inhibitors
02/21/2012CA2418962C Anti-dual integrin antibodies, compositions, methods and uses
02/21/2012CA2322055C Novel mechanically sensitive mammal potassium channel family activated by polyunsaturated fatty acids and their use particularly for screening medicines
02/21/2012CA2297303C Novel peptides and polypeptides useful for regenerating the nervous system
02/16/2012US20120041052 Compositions and Methods to Treat Muscular & Cardiovascular Disorders
02/16/2012US20120041050 Antisense oligonucleotides for inducing exon skipping and methods of use thereof
02/16/2012US20120041045 Use of pharmaceutical compositions containing mesembrenone
02/16/2012US20120040987 Derivatives of 6-(6-nh-substituted-triazolopyridazine-sulfanyl) benzothiazoles and benzimidazoles, preparation thereof, use thereof as drugs, and use thereof as met inhibitors
02/16/2012US20120040979 Imidazo[1,2-b]pyridazines, processes, uses, intermediates and compositions
02/16/2012US20120040935 Compositions useful as inhibitors of voltage-gated ion channels
02/16/2012US20120040012 Therapeutic stem cell nutrient composition and uses thereof
02/16/2012US20120039961 Implant and therapeutic composition for treating damage and/or diseases relating to the human animal musculoskeletal system
02/16/2012US20120039951 Compositions and methods for enhancing physiological performance and recovery time
02/16/2012US20120039940 Methods for treating uterine disorders
02/16/2012US20120039862 Extended Length Botulinum Toxin Formulation for Human or Mammalian Use
02/16/2012CA2807762A1 Methods for making a tissue engineered muscle repair (temr) construct in vitro for implantation in vivo
02/15/2012EP2417985A1 Mitochondrial function-improving agent
02/15/2012EP1633695B1 Smooth muscle spasmolytic agents
02/15/2012EP1381432B1 HSA-free formulations of interferon-beta
02/15/2012CN102351934A Steroidal alkaloid compounds and pharmaceutical composition thereof, as well as preparation methods and applications of steroidal alkaloid compounds and pharmaceutical composition of compounds
02/15/2012CN102349940A Process for preparing thermopsis lanceolate total alkaloids and several high-purity medicinal substances
02/15/2012CN102349914A Pharmaceutical compositions containing 3, 4-propinoperhydropurines and uses thereof for blocking neuronal transmission
02/15/2012CN101948464B 3,4,6-三芳基-[1,3]-噁嗪-2-酮类化合物、其制备方法和用途 3,4,6-triaryl - [1,3] - oxazin-2-ones compounds, their preparation and use
02/14/2012US8114999 Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase
02/14/2012US8114838 Methods for protecting dopaminergic neurons from stress and promoting proliferation and differentiation of oligodendrocyte progenitors by NRG-2
02/09/2012WO2012019071A1 Methods of preventing and treating sarcopenia
02/09/2012WO2012019002A2 Somatic stem cells
02/09/2012WO2012018257A1 Antisense oligonucleotide directed removal of proteolytic cleavage sites from proteins
02/09/2012WO2012016930A1 Compound useful for the treatment of nonsense-mutation-mediated diseases and pharmaceutical composition comprising said compound
02/09/2012US20120035265 Compositions, methods, and devices for the treatment of dysmenorrhea
02/09/2012US20120035251 Thiophene inhibitors of ikk-b serine-threonine protein kinase
02/09/2012US20120035239 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses
02/09/2012US20120035192 Selective antagonists of a2a adenosine receptors
02/09/2012US20120035164 Chemical compounds
02/09/2012US20120035154 Modulators of Cellular Adhesion
02/09/2012US20120035150 Mif inhibitors and their uses
02/09/2012US20120034303 Pharmaceutical formulation comprising one or more fumaric acid esters in an erosion matrix
02/09/2012US20120034195 Placental stem cells derive from post-partum manmalian placenta, and uses and methods of treatment using said cells
02/09/2012US20120034194 Somatic Stem Cells
02/09/2012US20120034193 Treatment of neurotrophic factor mediated disorders
02/09/2012US20120034159 Antibodies that bind both bcma and taci
02/09/2012US20120031785 Compositions and methods for increasing lean muscle mass and/or reducing fat gain
02/09/2012CA2807187A1 Antisense oligonucleotide directed removal of proteolytic cleavage sites from proteins
02/09/2012CA2806825A1 Compound useful for the treatment of nonsense-mutation-mediated diseases and pharmaceutical composition comprising said compound
02/08/2012CN102344442A Novel crystal form of tandospirone citrate and preparation method and application thereof
02/08/2012CN102343005A Chinese medicine for treating seborrheic alopecia
02/08/2012CN102342301A Foliage conditioner prepared from straw and household kitchen biomass carbonization byproducts and application thereof
02/08/2012CN101874846B Method for preparing cataplasm for treating soft tissue injury
02/08/2012CN101766746B 外用蜂毒擦剂 Topical liniment venom
02/07/2012US8110598 Heterocyclic compounds, their preparation, pharmaceutical compositions containing them and their use in medicine
02/07/2012US8110549 Alpha-conotoxin peptides
02/07/2012US8110177 Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions
02/02/2012WO2012014994A1 Naphthalene derivative
02/02/2012WO2012014890A1 NUCLEIC ACID MOLECULE CAPABLE OF BINDING TO c-Met AND USE THEREOF
02/02/2012WO2012012843A1 Modulators of protease activated receptors
1 ... 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 ... 233